Chi, K N, Adra, N, Garje, R, Michalski, J M, Lavalaye, J, Kempel, M M, Brackman, M, Perraud, K, Holder, G & Armstrong, A J 2022, ' Exposure-adjusted safety analyses of the VISION phase 3 trial of 177 Lu-PSMA-617 in patients with metastatic castration-resistant prostate cancer. ', Journal of Clinical Oncology, vol. 40, no. Suppl. 6, pp. 85 . https://doi.org/10.1200/JCO.2022.40.6_suppl.085